Global Private Capital Investors

Last registered on October 23, 2024

Pre-Trial

Trial Information

General Information

Title
Global Private Capital Investors
RCT ID
AEARCTR-0014577
Initial registration date
October 14, 2024

Initial registration date is when the trial was registered.

It corresponds to when the registration was submitted to the Registry to be reviewed for publication.

First published
October 18, 2024, 5:06 PM EDT

First published corresponds to when the trial was first made public on the Registry after being reviewed.

Last updated
October 23, 2024, 5:24 PM EDT

Last updated is the most recent time when changes to the trial's registration were published.

Locations

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information

Primary Investigator

Affiliation

Other Primary Investigator(s)

PI Affiliation
Harvard Business School

Additional Trial Information

Status
In development
Start date
2024-10-31
End date
2025-08-31
Secondary IDs
Prior work
This trial does not extend or rely on any prior RCTs.
Abstract
This study aims to examine investment preferences of global private capital investors across a diverse set of company attributes. The study is conducted in collaboration with the International Finance Corporation (IFC). We aim to measure both average investment preferences and variations in preferences across different sociodemographic groups of angel investors.
External Link(s)

Registration Citation

Citation
Colonnelli, Emanuele and Josh Lerner. 2024. "Global Private Capital Investors." AEA RCT Registry. October 23. https://doi.org/10.1257/rct.14577-1.1
Experimental Details

Interventions

Intervention(s)
This study aims to examine investment preferences of global private capital investors across a diverse set of company attributes.
Intervention Start Date
2024-10-31
Intervention End Date
2025-08-31

Primary Outcomes

Primary Outcomes (end points)
Interest in investing in specific companies.
Primary Outcomes (explanation)

Secondary Outcomes

Secondary Outcomes (end points)
Secondary Outcomes (explanation)

Experimental Design

Experimental Design
This study aims to examine investment preferences of global private capital investors across a diverse set of company attributes using experimental surveys.
Experimental Design Details
Not available
Randomization Method
Randomization done in office by a computer
Randomization Unit
Company level being evaluated
Was the treatment clustered?
No

Experiment Characteristics

Sample size: planned number of clusters
We hope to reach at least 1000 investors
Sample size: planned number of observations
expected to be 15000
Sample size (or number of clusters) by treatment arms
See PAP
Minimum detectable effect size for main outcomes (accounting for sample design and clustering)
IRB

Institutional Review Boards (IRBs)

IRB Name
Social & Behavioral Sciences IRB Office
IRB Approval Date
2024-01-22
IRB Approval Number
IRB24-0116
Analysis Plan

There is information in this trial unavailable to the public. Use the button below to request access.

Request Information